"GW Pharmaceuticals engages in the research, development and commercialization of a range of cannabinoid prescription medicines." read more

EMPLOYEE PARTICIPANTS: 11

TOTAL RATINGS: 111

CEO: Kevin Rountree

GW CEO & Leadership Team Ratings

Kevin Rountree and the GW leadership team are scored a "B" by 10 employees placing it in the Top 35% of companies sized 201-500 Employees. The Leadership Score of 72/100 is based on 31 ratings; it combines employee feedback on their CEO (76/100), Manager (70/100), and Executive Team (71/100).

Kevin Rountree GW CEO Rating

Top 15% Compared to other companies of similar size in Minneapolis

A-

76 / 100

Kevin Rountree the CEO of GW received an average score of 76 from GW employees.

Male employees at GW rate the CEO the highest.

Male: 80

Female: 77

The Engineering department at GW rate the CEO the highest.

Engineering: 73

Employees who have been at GW for Less Than 1 Year rate the CEO the highest.

Less Than 1 Year

GW Manager Rating

Top 50% Compared to other companies of similar size in Minneapolis

C+

70 / 100

Managers received an average score of 70 from GW employees.

Female employees at GW rate their Manager the highest.

Male:

Female: 77

Employees who have been at GW for Less Than 1 Year rate their Manager the highest.

Less Than 1 Year

GW Executive Team Rating

Top 35% Compared to other companies of similar size in Minneapolis

71 / 100

The Executive team received an average score of 71 from GW employees.

Rate your company